Detect, Inc. is voluntarily recalling 3 lots of the Detect COVID-19 Test™ due to an increased risk of false negative results. The Detect COVID-19 Test is a molecular, over-the-counter test used to identify SARS-CoV-2 in self-collected nasal swabs. The affected lots (HB264, HY263, and HY264) were distributed to customers from July 26, 2022 to August…
The combined vaccine is intended to simplify immunization practices against 2 severe respiratory diseases caused by evolving viruses that require vaccine adaptation.
The all-oral and combination treatment arms demonstrated statistically significant composite responses of 10.1% and 19.2%, respectively.
As part of the Choosing Wisely campaign, the American Academy of Pediatrics (AAP) has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question. Choosing Wisely is an American Board of Internal Medicine (ABIM) Foundation initiative that aims to promote discussions between clinicians and…
The investigational intravenous product is a combination of sulbactam, a β-lactam antibiotic, and durlobactam, a broad-spectrum β-lactamase inhibitor.
The CDC Nowcast data show that as of last week the BQ.1 and BQ.1.1 subvariants accounted for more than 57% of COVID-19 cases.
The product is administered rectally 24 to 72 hours after the last dose of antibiotics for CDI.
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
The guidance provides steps to address the potential for cross-contamination.
For regions with high levels of RSV disease activity in the fall and winter, the AAP supports the use of more than 5 consecutive doses of palivizumab to eligible infants.
